HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J C Keith Selected Research

oprelvekin (Neumega)

10/2001Recombinant human interleukin-11 restores smooth muscle function in the jejunum and colon of human leukocyte antigen-B27 rats with intestinal inflammation.
3/2001Effect of recombinant human interleukin-11 on motilin and substance P release in normal and inflamed rabbits.
9/2000Dose-dependent effects of recombinant human interleukin-11 on contractile properties in rabbit 2,4,6-trinitrobenzene sulfonic acid colitis.
8/2000Recombinant human interleukin-11 decreases severity of acute necrotizing pancreatitis in mice.
8/2000Recombinant human interleukin-11 modulates ion transport and mucosal inflammation in the small intestine and colon.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J C Keith Research Topics

Disease

4Inflammation (Inflammations)
10/2001 - 08/2000
3Colitis
03/2001 - 08/2000
2Hemophilia B (Haemophilia B)
05/2002 - 03/2001
2Diarrhea
10/2001 - 08/2000
2Infections
04/2001 - 02/2000
1Rheumatoid Arthritis
11/2008
1Experimental Arthritis
11/2008
1Arthritis (Polyarthritis)
11/2008
1Albuminuria
01/2005
1Glomerulonephritis
01/2005
1Pre-Eclampsia (Preeclampsia)
11/2001
1Peritonitis
04/2001
1Bacterial Infections (Bacterial Infection)
04/2001
1Bacteremia
04/2001
1Sepsis (Septicemia)
04/2001
1Endotoxemia
08/2000
1Thoracic Injuries (Chest Injury)
08/2000
1Anemia
08/2000
1Pancreatitis
08/2000
1Hemorrhage
08/2000
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2000
1Edema (Dropsy)
08/2000
1Acute Necrotizing Pancreatitis
08/2000
1Necrosis
07/2000
1Listeriosis (Listeria Infection)
02/2000

Drug/Important Bio-Agent (IBA)

8Interleukin-11 (Interleukin 11)IBA
01/2005 - 02/2000
5oprelvekin (Neumega)FDA Link
10/2001 - 08/2000
4CytokinesIBA
04/2001 - 02/2000
3Proteins (Proteins, Gene)FDA Link
11/2001 - 09/2000
2Factor IX (Coagulation Factor IX)FDA LinkGeneric
05/2002 - 03/2001
2HLA-B27 Antigen (HLA B27 Antigen)IBA
10/2001 - 08/2000
2Peroxidase (Myeloperoxidase)IBA
10/2001 - 08/2000
2Substance PIBA
03/2001 - 09/2000
2MotilinIBA
03/2001 - 09/2000
1Therapeutic UsesIBA
01/2005
1FibrinIBA
01/2005
1NF-kappa B (NF-kB)IBA
01/2005
1syncytinIBA
11/2001
1Carbachol (Carbastat)FDA Link
10/2001
1HLA Antigens (Human Leukocyte Antigens)IBA
10/2001
1Glycoproteins (Glycoprotein)IBA
04/2001
1Immunoglobulin G (IgG)IBA
04/2001
1LigandsIBA
04/2001
1P-SelectinIBA
04/2001
1NeuropeptidesIBA
03/2001
1Acetylcholine (Acetylcholine Chloride)FDA Link
09/2000
1sym-trinitrobenzeneIBA
09/2000
1ProstaglandinsIBA
09/2000
1Sulfonic AcidsIBA
09/2000
1CollagenIBA
09/2000
1Messenger RNA (mRNA)IBA
08/2000
1Eosine Yellowish-(YS) (Eosin)IBA
08/2000
1Hematoxylin (Haematoxylon)IBA
08/2000
1CeruletideIBA
08/2000
1InterleukinsIBA
08/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2000
1Interferon-gamma (Interferon, gamma)IBA
07/2000
1InterferonsIBA
07/2000
1Fibronectins (Fibronectin)IBA
07/2000

Therapy/Procedure

3Therapeutics
11/2008 - 03/2001
1Oral Administration
10/2001
1Ligation
04/2001
1Punctures
04/2001
1Hemodilution
08/2000
1Intraperitoneal Injections
08/2000